Rodger MA et al. – Dalteparin and tinzaparin significantly accumulate in hemodialysis (HD) patients at therapeutic doses. “Bridging therapy” with low–molecular–weight heparins at therapeutic doses in HD patients who require temporary interruption of warfarin therapy has the potential for complications and is of uncertain benefit.Methods
© 2015 M3 USA Corporation. ALL Rights Reserved.